Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
Sign Up to like & getrecommendations! Published in 2023 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14308
Abstract: Since the withdrawal of HeartWare (HVAD) from the global market, there is an ongoing discussion if and which patients require prophylactically exchange for a HeartMate 3 (HM3). Therefore, it is important to study outcome differences… read more here.
Keywords: risk multi; identifying patients; multi centre; patients risk ... See more keywords